Effects of dacomitinib on the pharmacokinetics of poziotinib in vivo and in vitro

Ji, WP; Shen, JQ; Wang, B; Chen, FF; Meng, DR; Wang, SH; Dai, DP; Zhou, YF; Wang, CX; Zhou, Q

Zhou, YF; Zhou, Q (corresponding author), Wenzhou Med Univ, Peoples Hosp Lishui, Affiliated Hosp 6, Lab Clin Pharm, Lishui 323000, Peoples R China.; Wang, CX (corresponding author), Wenzhou Med Univ, Peoples Hosp Lishui, Dept Gastroenterol, Affiliated Hosp 6, Lishui 323000, Peoples R China.

PHARMACEUTICAL BIOLOGY, 2021; 59 (1): 457

Abstract

Context Dacomitinib and poziotinib, irreversible ErbB family blockers, are often used for treatment of non-small cell lung cancer (NSCLC) in the clini......

Full Text Link